Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6402 posts found.

Drugmakers fined a record £260 million after 10,000% drug price increase

July 16, 2021 Medical Communications UK

The UK’s competition authority has issued its largest ever fine of more than £260 million ($360 million) to several pharma …
News

Younger adults with COVID still at risk of serious organ damage

July 16, 2021 Medical Communications

Young adults admitted to hospital with COVID-19 are almost as likely to experience complications as those over 50, a study …
News

EMA validates HUTCHMED MAA for neuroendocrine tumour drug

July 16, 2021 Medical Communications EU, oncology

China-based biotech HUTCHMED has announced that the EMA has validated and accepted the Marketing Authorisation Application (MAA) for surufatinib, for …
News

NICE rejects gene therapy for children with neurodegenerative disorder

July 9, 2021 Medical Communications

NICE does not recommend gene therapy OTL-200 (also called Libmeldy and made by Orchard Therapeutics) for treating children with the …
News

FDA narrows guidance on controversial Alzheimer’s drug

July 9, 2021 Medical Communications

A month after the approval of Biogen’s controversial new Alzheimer’s drug, Aduhelm, the FDA has narrowed its guidance on who …
News
biogen_austria_238

Global genetic exome sequence analysis collaboration announced

July 9, 2021 Medical Communications

AbbVie, Pfizer, and Biogen have announced the launch of the world’s largest browsable resource linking rare protein-coding genetic variants to …
News

Tech successful in harvesting cancer cells in brain metastases patients

July 9, 2021 Medical Communications

The University Medical Centre Hamburg-Eppendorf has published results of new work undertaken in patients with brain metastasis using ANGLE’s cell …
News

Children “extremely low risk” from COVID study finds

July 9, 2021 Medical Communications COVID-19, Vaccine

The overall risk of children becoming severely ill or dying from COVID-19 is extremely low, scientists from University College London, …
News
az

AstraZeneca MPO inhibitor shows promise for heart failure patients

July 2, 2021 Medical Communications

Results released from AstraZeneca’s Phase IIa SATELLITE trial demonstrated that AZD4831, a myeloperoxidase (MPO) inhibitor, achieved pre-specified target engagement in …
News
img_4190-e1376666350337

Congenital adrenal hyperplasia treatment granted MHRA authorisation

July 2, 2021 Medical Communications

The MHRA has granted marketing authorisation to Diurnal’s treatment, Efmody, as treatment of adult and adolescent patients with the rare …
News

J&J COVID vaccine effective against Delta variant

July 2, 2021 Medical Communications

Johnson & Johnson (J&J) has reported that its single-dose Covid-19 vaccine stimulated robust, continued neutralising antibody activity against the Delta …
News

Travellers with Indian-made AZ jab may face European ban

July 2, 2021 Medical Communications COVID-19, India, Vaccine

Up to 5 million Britons planning to travel to Europe may face a travel ban if they have been vaccinated …
News
sachet

Origin Group launches fully recyclable sachet for health sector

July 2, 2021 Medical Communications

The Origin Group has launched a 100% recyclable single-dose sachet which is fully brandable for the health sector. The new …
News

PrecisionLife appoints Ray Pawlicki as Executive Chair to the board of directors

June 30, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

PrecisionLife Limited has appointed Ray Pawlicki, previously CIO at Biogen and Novartis, as Executive Chair to the board of directors.Widely …
Appointment
golo_von_basum

New Chief Operating Officer for Dutch MedTech STENTiT

June 30, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Medical device company STENTiT has appointed Dr Golo von Basum as its Chief Operating Officer.He will be responsible for the …
Appointment
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025